382 related articles for article (PubMed ID: 27146557)
1. Engineering Delivery Vehicles for Genome Editing.
Nelson CE; Gersbach CA
Annu Rev Chem Biomol Eng; 2016 Jun; 7():637-62. PubMed ID: 27146557
[TBL] [Abstract][Full Text] [Related]
2. In Vivo Delivery Systems for Therapeutic Genome Editing.
Wang L; Li F; Dang L; Liang C; Wang C; He B; Liu J; Li D; Wu X; Xu X; Lu A; Zhang G
Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27128905
[TBL] [Abstract][Full Text] [Related]
3. Gene editing and CRISPR in the clinic: current and future perspectives.
Hirakawa MP; Krishnakumar R; Timlin JA; Carney JP; Butler KS
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32207531
[TBL] [Abstract][Full Text] [Related]
4. Genome editing: the road of CRISPR/Cas9 from bench to clinic.
Eid A; Mahfouz MM
Exp Mol Med; 2016 Oct; 48(10):e265. PubMed ID: 27741224
[TBL] [Abstract][Full Text] [Related]
5. Genome engineering: a new approach to gene therapy for neuromuscular disorders.
Nelson CE; Robinson-Hamm JN; Gersbach CA
Nat Rev Neurol; 2017 Nov; 13(11):647-661. PubMed ID: 28960187
[TBL] [Abstract][Full Text] [Related]
6. Delivery technologies for genome editing.
Yin H; Kauffman KJ; Anderson DG
Nat Rev Drug Discov; 2017 Jun; 16(6):387-399. PubMed ID: 28337020
[TBL] [Abstract][Full Text] [Related]
7. INDEL detection, the 'Achilles heel' of precise genome editing: a survey of methods for accurate profiling of gene editing induced indels.
Bennett EP; Petersen BL; Johansen IE; Niu Y; Yang Z; Chamberlain CA; Met Ö; Wandall HH; Frödin M
Nucleic Acids Res; 2020 Dec; 48(21):11958-11981. PubMed ID: 33170255
[TBL] [Abstract][Full Text] [Related]
8. Engineering of Zinc Finger Nucleases Through Structural Modeling Improves Genome Editing Efficiency in Cells.
Katayama S; Watanabe M; Kato Y; Nomura W; Yamamoto T
Adv Sci (Weinh); 2024 Jun; 11(23):e2310255. PubMed ID: 38600709
[TBL] [Abstract][Full Text] [Related]
9. In Vivo Genome Editing as a Therapeutic Approach.
Ho BX; Loh SJH; Chan WK; Soh BS
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30213032
[TBL] [Abstract][Full Text] [Related]
10. Genome centric engineering using ZFNs, TALENs and CRISPR-Cas9 systems for trait improvement and disease control in Animals.
Wani AK; Akhtar N; Singh R; Prakash A; Raza SHA; Cavalu S; Chopra C; Madkour M; Elolimy A; Hashem NM
Vet Res Commun; 2023 Jan; 47(1):1-16. PubMed ID: 35781172
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic editing of hepatocyte genome in vivo.
Ruiz de Galarreta M; Lujambio A
J Hepatol; 2017 Oct; 67(4):818-828. PubMed ID: 28527665
[TBL] [Abstract][Full Text] [Related]
12. Development of Toolboxes for Precision Genome/Epigenome Editing and Imaging of Epigenetics.
Nomura W
Chem Rec; 2018 Dec; 18(12):1717-1726. PubMed ID: 30066981
[TBL] [Abstract][Full Text] [Related]
13. Genome Editing in Human Pluripotent Stem Cells.
Carlson-Stevermer J; Saha K
Methods Mol Biol; 2017; 1590():165-174. PubMed ID: 28353269
[TBL] [Abstract][Full Text] [Related]
14. [Applications of ZFN, TALEN and CRISPR/Cas9 techniques in disease modeling and gene therapy].
Zhao G; Pu J; Tang B
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Dec; 33(6):857-862. PubMed ID: 27984622
[TBL] [Abstract][Full Text] [Related]
15. [CRISPR/Cas9 technology in disease research and therapy: a review].
Shi M; Shen Z; Zhang N; Wang L; Yu C; Yang Z
Sheng Wu Gong Cheng Xue Bao; 2021 Apr; 37(4):1205-1228. PubMed ID: 33973436
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Genome Editing and In Vivo Delivery.
Ramirez-Phillips AC; Liu D
AAPS J; 2021 Jun; 23(4):80. PubMed ID: 34080099
[TBL] [Abstract][Full Text] [Related]
17. Non-viral strategies for delivering genome editing enzymes.
Li J; Røise JJ; He M; Das R; Murthy N
Adv Drug Deliv Rev; 2021 Jan; 168():99-117. PubMed ID: 32931860
[TBL] [Abstract][Full Text] [Related]
18. Enhanced genome editing in mammalian cells with a modified dual-fluorescent surrogate system.
Zhou Y; Liu Y; Hussmann D; Brøgger P; Al-Saaidi RA; Tan S; Lin L; Petersen TS; Zhou GQ; Bross P; Aagaard L; Klein T; Rønn SG; Pedersen HD; Bolund L; Nielsen AL; Sørensen CB; Luo Y
Cell Mol Life Sci; 2016 Jul; 73(13):2543-63. PubMed ID: 26755436
[TBL] [Abstract][Full Text] [Related]
19. Research on genodermatoses using novel genome-editing tools.
Lehmann J; Seebode C; Emmert S
J Dtsch Dermatol Ges; 2017 Aug; 15(8):783-789. PubMed ID: 28622433
[TBL] [Abstract][Full Text] [Related]
20. CRISPR-Based Genome Editing as a New Therapeutic Tool in Retinal Diseases.
Rasoulinejad SA; Maroufi F
Mol Biotechnol; 2021 Sep; 63(9):768-779. PubMed ID: 34057656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
